Toll-like receptor 4 in COVID-19: friend or foe?

被引:37
|
作者
Mukherjee, Suprabhat [1 ]
机构
[1] Kazi Nazrul Univ, Dept Anim Sci, Integrat Biochem & Immunol Lab, Asansol 713340, W Bengal, India
关键词
COVID-19; cytokine storm; immunotherapy; SARS-CoV-2; TLR4; TLR4;
D O I
10.2217/fvl-2021-0249
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Tweetable abstract Toll-like receptor 4, an innate immune sensor, is one of the key 'fate-deciding' regulators of immunity as well as COVID-19 immunopathogenesis. Suitable targeting of Toll-like receptor 4 appears to be an effective strategy to counteract the pandemic.
引用
收藏
页码:415 / 417
页数:3
相关论文
共 50 条
  • [41] Role of toll-like receptors in post-COVID-19 associated neurodegenerative disorders?
    Satyanarayanan, Senthil Kumaran
    Yip, Tsz Fung
    Han, Zixu
    Zhu, Huachen
    Qin, Dajiang
    Lee, Suki Man Yan
    FRONTIERS IN MEDICINE, 2025, 12
  • [42] Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19
    Manik, Moumita
    Singh, Rakesh K.
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (03) : 869 - 877
  • [43] Role of toll-like receptor in the pathogenesis of oral cancer
    Ananya Bhardwaj
    Divya Prasad
    Sayali Mukherjee
    Cell Biochemistry and Biophysics, 2024, 82 : 91 - 105
  • [44] Toll-like receptor 9 agonists as cancer therapeutics
    Holtick, Udo
    Scheulen, Max E.
    von Bergwelt-Baildon, Michael S.
    Weihrauch, Martin R.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (03) : 361 - 372
  • [45] Role of toll-like receptor in the pathogenesis of oral cancer
    Bhardwaj, Ananya
    Prasad, Divya
    Mukherjee, Sayali
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2024, 82 (01) : 91 - 105
  • [46] Friend or Foe? Implication of the autophagy-lysosome pathway in SARS-CoV-2 infection and COVID-19
    He, Weifeng
    Gao, Yuan
    Zhou, Jing
    Shi, Yi
    Xia, Dajing
    Shen, Han-Ming
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (11): : 4690 - 4703
  • [47] Friend or Foe? Implication of the autophagy-lysosome pathway in SARS-CoV-2 infection and COVID-19
    He, Weifeng
    Gao, Yuan
    Zhou, Jing
    Shi, Yi
    Xia, Dajing
    Shen, Han-Ming
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (12): : 4690 - 4703
  • [48] The Use of Toll-like Receptor 4 Agonist to Reshape the Immune Signature in Ovarian Cancer
    Vindevogel, Eva
    Baert, Thais
    Van Hoylandt, Anais
    Verbist, Godelieve
    Vande Velde, Greetje
    Garg, Abhishek D.
    Agostinis, Patricia
    Vergote, Ignace
    Coosemans, An
    ANTICANCER RESEARCH, 2016, 36 (11) : 5781 - 5792
  • [49] Peripheral blood toll-like receptor 4 correlates response to candida immunotherapy of warts
    Sabry, Hanan H.
    Hamed, Ahmed M.
    Salem, Rehab M.
    Marei, Ayman Mohamed
    El Sebaey, Roaa Mohamed
    DERMATOLOGIC THERAPY, 2018, 31 (05)
  • [50] Toll-like receptor 4 in acute viral infection: Too much of a good thing
    Olejnik, Judith
    Hume, Adam J.
    Muhlberger, Elke
    PLOS PATHOGENS, 2018, 14 (12)